BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2876040)

  • 1. Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.
    Kalland T
    J Immunol; 1986 Oct; 137(7):2268-71. PubMed ID: 2876040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
    Migliorati G; Cannarile L; Herberman RB; Bartocci A; Stanley ER; Riccardi C
    J Immunol; 1987 Jun; 138(11):3618-25. PubMed ID: 2884255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of natural killer cells from bone marrow precursors in vitro.
    Kalland T
    Immunology; 1986 Apr; 57(4):493-8. PubMed ID: 3485566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3.
    Kalland T
    J Immunol; 1987 Dec; 139(11):3671-5. PubMed ID: 3500227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor phenotype of lymphokine-activated killer cells in the mouse.
    Salup RR; Mathieson BJ; Wiltrout RH
    J Immunol; 1987 Jun; 138(11):3635-9. PubMed ID: 3108370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of cytotoxic cells from murine bone marrow by human recombinant IL 2.
    Koo GC; Manyak CL
    J Immunol; 1986 Sep; 137(6):1751-6. PubMed ID: 2427580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cultures of mouse bone marrow cells: a model for studying the generation of natural killer cells.
    Ayroldi E; Cannarile L; D'Adamio F; Delfino D; Migliorati G; Riccardi C
    Nat Immun; 1992; 11(6):317-27. PubMed ID: 1477494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of NK cell activity from human bone marrow.
    Lotzová E; Savary CA
    J Immunol; 1987 Jul; 139(1):279-84. PubMed ID: 3495600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency.
    Garni-Wagner BA; Witte PL; Tutt MM; Kuziel WA; Tucker PW; Bennett M; Kumar V
    J Immunol; 1990 Feb; 144(3):796-803. PubMed ID: 2136898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of natural killer cell differentiation by activated T lymphocytes in long-term cultures of mouse bone marrow.
    Delfino DV; Lepri E; Ayroldi E; Migliorati G; Boggs SS; Riccardi C
    Exp Hematol; 1998 Jan; 26(1):2-9. PubMed ID: 9430508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant murine tumor necrosis factor on the generation of natural killer cells in bone marrow cultures.
    Ayroldi E; Sorci G; Cannarile L; Riccardi C
    Nat Immun; 1992; 11(2):92-104. PubMed ID: 1498522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of natural killer cell lines from murine long-term bone marrow cultures.
    Yung YP; Okumura K; Moore MA
    J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 augments the interleukin-2-dependent generation of natural killer cells from bone marrow precursors.
    Migliorati G; Cannarile L; D'Adamio L; Herberman RB; Riccardi C
    Nat Immun Cell Growth Regul; 1987; 6(6):306-15. PubMed ID: 3502358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of natural killer cells from long-term cultures of mouse bone marrow.
    Vecchini F; Delfino D; Patrene KD; DeLeo A; Lu L; Herberman RB; Boggs SS
    Nat Immun; 1993; 12(1):1-16. PubMed ID: 8431659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    Suzuki R; Handa K; Itoh K; Kumagai K
    J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
    Lotzová E; Savary CA
    Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG; Deal H; Reid D; Eaves CJ
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer (NK) cell activity during lymphatic regeneration: early appearance of Thy-1+ NK cells and highly interleukin 2-(IL 2) receptive, Thy-1- cells.
    Hurme M; Sihvola M
    J Immunol; 1983 Aug; 131(2):658-61. PubMed ID: 6134773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.